Novartis Institutes for BioMedical Research (NIBR)
NIBR is the global pharmaceutical research organization of Novartis. With approximately 6,000 scientists and physicians around the world, our research is focused on discovering innovative new drugs that will change the practice of medicine. We have an open and entrepreneurial culture, encouraging collaboration to make effective therapies. We have an open and entrepreneurial culture, encouraging collaboration internally and externally to make effective therapies. Today, our research benefits from an external network of more than 300 academic and 100 industry alliances focused on areas of mutual scientific interest.